Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCF-013 3,′6-d isinapoyl sucrose
>98%,Standard References
More description
DCZ-251 Sanguinarine Sulfate
>98%,Standard References
More description
DCY-134 O-diacetyldaurisoline
>98%,Standard References
More description
DCS-085 R-Notoginsenoside R2
>98%,Standard References
More description
DCY-089 alpha-boswellic acid,3-acetyl
>98%,Standard References
More description
DCY-090 beta-boswellic acid,3-acetyl,11-keto
>98%,Standard References
More description
DCJ-047 25-OCH3-Protopanaxtiol
>98%,Standard References
More description
DCJ-060 3’-Methoxy apiin;Chrysoeiol-7-(2-O-apiosylglucoside)
>98%,Standard References
More description
DCJ-068 Sanguinarine citrate
>98%,Standard References
More description
DCG-023 Epimeredinoside A
>98%,Standard References
More description
DCY-175 Icarisid II
>98%,Standard References
More description
DCS-097 1,3,5,8-Tetrahydroxylxanthone
>98%,Standard References
More description
DCS-112 Ochnaflavone7-O-β-D-gluco-pyranoside
>98%,Standard References
More description
DCY-129 Acetytastragaloside
>98%,Standard References
More description
DCF-009 beta-rosasterol
>98%,Standard References
More description
DCY-141 Yejunualactone
>98%,Standard References
More description
DCJ-050 3’-methoxy-5’-hydroxyisoflavone-7-O-β-D-glucoside
>98%,Standard References
More description
DCY-113 Acevaltratum
>98%,Standard References
More description
DCY-142 Ginkgolic acids
>98%,Standard References
More description
DCZ-129 Panax notoginsenosides
>98%,Standard References
More description
DCZ-153 paclitaxtide
>98%,Standard References
More description
DC12522 MKK7-COV-3 Featured
MKK7-COV-3 (MKK7 Covalen inhibitor 3) is a potent, selective, covalent MKK7 inhibitor with in vitro IC50 of 5 nM, displays >1,000-fold selectivity over MKK4 (IC50=7.81 uM), shows EC50 of 1.3 uM for reduction of p-JNK in ICW assays in Beas2B cell line, wit
More description
DC22215 RO 27-3225 Featured
RO 27-3225 (RO27-3225, RO 273225) is a potent, selective melanocortin melanocortin receptor MC4R agonist with EC50 of 1 nM, >30-fold selectivity over MC3R.
More description
DC21644 SHP504 Featured
SHP504 is a distinct, allosteric site 2 SHP2 inhibitor with IC50 of 21 uM (SHP2 1-525), and selective over the phosphatase domain (SHP2 PTP IC50>100 uM).downregulates DUSP6 mRNA, a downstream MAPK pathway marker, in KYSE-520 cancer cells.
More description
DC39094 JHU395
JHU395 is a novel orally bioavailable GA (glutamine antagonists) prodrug designed to circulate inert in plasma, but permeate and release active GA within target tissues. JHU395 delivers active GA to malignant peripheral nerve sheath tumor (MPNST), and significantly inhibits tumor growth without observed toxicity.
More description
DC39081 BCH
BCH (LAT1-IN-1) is a selective and competitive inhibitor of system L amino acid transporter 1 (LAT1). BCH (LAT1-IN-1) induces apoptosis in cancer cells.
More description
DC33598 GSK-805 Featured
GSK805, also known as ROR gamma-t-IN-1, is a potent, orally bioavailable retinoid-related orphan receptor gamma t (RORγt) inverse agonist that interacts with the receptor's putative ligand binding domain without exerting significant effects on DNA binding.
More description
DC20613 A-800141
A-800141 is a potent, highly specific, orally bioavailable MetAP2 inhibitor with IC50 of 12 nM, shows no inhibition for MetAP1 (IC50>30 uM).
More description
DC26022 Tenofovir exalidex(CMX157)
Tenofovir exalidex is a novel lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir.
More description
DC25028 AUDA Featured
A potent inhibitor of sEH (soluble epoxide hydrolase) with IC50 of 18 nM and 69 nM for mouse sEH and human sEH, respectively.
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X